Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease
- PMID: 9434102
- DOI: 10.1016/s0925-4439(97)00070-7
Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease
Abstract
The dopaminergic neurotoxin N-methyl,4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) causes a syndrome in primates and humans which mimics Parkinson's disease (PD) in clinical, pathological, and biochemical findings, including diminished activity of complex I in the mitochondrial electron transport chain. Reduced complex I activity is found in sporadic PD and can be transferred through mitochondrial DNA, suggesting a mitochondrial genetic etiology. We now show that MPTP treatment of mice and N-methylpyridinium (MPP+) exposure of human SH-SY5Y neuroblastoma cells increases oxygen free radical production and antioxidant enzyme activities. Cybrid cells created by transfer of PD mitochondria exhibit similar characteristics; however, PD cybrids' antioxidant enzyme activities are not further increased by MPP+ exposure, as are the activities in control cybrids. PD mitochondrial cybrids are subject to metabolic and oxidative stresses similar to MPTP parkinsonism and provide a model to determine mechanisms of oxidative damage and cell death in PD.
Similar articles
-
Mitochondrial toxins in models of neurodegenerative diseases. I: In vivo brain hydroxyl radical production during systemic MPTP treatment or following microdialysis infusion of methylpyridinium or azide ions.Brain Res. 1997 Aug 15;765(2):183-8. doi: 10.1016/s0006-8993(97)00429-0. Brain Res. 1997. PMID: 9313890
-
Nimodipine, an L-type calcium channel blocker attenuates mitochondrial dysfunctions to protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.Neurochem Int. 2016 Oct;99:221-232. doi: 10.1016/j.neuint.2016.07.003. Epub 2016 Jul 7. Neurochem Int. 2016. PMID: 27395789
-
The influence and the mechanism of docosahexaenoic acid on a mouse model of Parkinson's disease.Neurochem Int. 2011 Oct;59(5):664-70. doi: 10.1016/j.neuint.2011.06.012. Epub 2011 Jun 28. Neurochem Int. 2011. PMID: 21736911
-
Are free radicals involved in the pathogenesis of idiopathic Parkinson's disease?Eur Neurol. 1993;33 Suppl 1:38-43. doi: 10.1159/000118536. Eur Neurol. 1993. PMID: 8375431 Review.
-
The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases.Mol Cell Biochem. 1997 Sep;174(1-2):193-7. Mol Cell Biochem. 1997. PMID: 9309687 Review.
Cited by
-
Puerarin protects against damage to spatial learning and memory ability in mice with chronic alcohol poisoning.Braz J Med Biol Res. 2015 Jun;48(6):515-22. doi: 10.1590/1414-431X20144250. Epub 2015 Mar 27. Braz J Med Biol Res. 2015. PMID: 25831201 Free PMC article.
-
A genome on shaky ground: exploring the impact of mitochondrial DNA integrity on Parkinson's disease by highlighting the use of cybrid models.Cell Mol Life Sci. 2022 May 5;79(5):283. doi: 10.1007/s00018-022-04304-3. Cell Mol Life Sci. 2022. PMID: 35513611 Free PMC article. Review.
-
Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons.J Neurosci. 2002 Feb 1;22(3):782-90. doi: 10.1523/JNEUROSCI.22-03-00782.2002. J Neurosci. 2002. PMID: 11826108 Free PMC article.
-
Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice.PLoS One. 2010 Aug 23;5(8):e12333. doi: 10.1371/journal.pone.0012333. PLoS One. 2010. PMID: 20808797 Free PMC article.
-
MPP+: mechanism for its toxicity in cerebellar granule cells.Mol Neurobiol. 2004 Dec;30(3):253-64. doi: 10.1385/MN:30:3:253. Mol Neurobiol. 2004. PMID: 15655251 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical